Cutaneous adverse reaction (includes severe cutaneous adverse drug reaction (SCAR))

• (2022): Dolinger MT+, J Crohns Colitis Apr, Online ahead of print

Eczema / eczematous reaction / eczematous eruption

• (2017): Nakamura M+, J Dermatolog Treat 28(3), 237 [REVIEW]
• (2017): Segaert S+, Am J Clin Dermatol 18(6), 771 [REVIEW] (orange-red psoriasiform)

Hand–foot syndrome (palmar–plantar erythrodysesthesia)

• (2017): Segaert S+, Am J Clin Dermatol 18(6), 771 [REVIEW]

Henoch-Schönlein purpura / IgA vasculitis / immunoglobulin A vasculitis

• (2025): Yan L+, Arch Dermatol Res 317(1), 445 (35 cases) [REVIEW]
• (2021): Rasmussen C+, Autoimmun Rev 20(1), 102707

Hypersensitivity

• (2015): Galvao VR+, J Allergy Clin Immunol Pract 3(2), 175 [REVIEW]

Lupus erythematosus (subacute cutaneous lupus erythematosus (SCLE))

• (2025): He M+, Sci Rep 15(1), 6838 [REVIEW] (association) (pharmacovigilance / pharmacoepidemiology)

Palmoplantar pustulosis

• (2022): Reolid A+, J Pers Med 12(9), 1452 (pharmacogenomics)

Psoriasis

• (2025): Gaston J+, Australas J Dermatol May, Online ahead of print [REVIEW] (paradoxical reaction)
• (2025): Im G+, Australas J Dermatol Jan, Online ahead of print (93 cases)
• (2023): Joulfayan H+, Sci Rep 13(1), 10448 (association)
• (2023): Sagonas I+, Clin Exp Rheumatol Oct, Online ahead of print0.5–1% [REVIEW] (paradoxical)
• (2020): Lian N+, Dermatol Ther Aug, e142257% (paradoxical psoriasis)
• (2018): Andrade P+, Dig Dis Sci Jan, Epub ahead of print5%
• (2018): Mazloom SE+, J Am Acad Dermatol Dec, Epub ahead of print102 cases [REVIEW]
• (2017): Balak DM+, Psoriasis (Auckl) 7, 87 [REVIEW]
• (2017): Brown G+, J Am Acad Dermatol 76(2), 334 [REVIEW]
• (2017): Craddock LN+, Dermatol Online J 23(3), Epub
• (2017): Segaert S+, Am J Clin Dermatol 18(6), 771 [REVIEW]

Sarcoidosis / sarcoid-like reaction (cutaneous sarcoidosis)

• (2019): Cohen Aubart F+, J Intern Med Oct, Epub ahead of print [REVIEW]

Skin cancer

• (2018): Andrade P+, Dig Dis Sci Jan, Epub ahead of print1%
• (2017): Segaert S+, Am J Clin Dermatol 18(6), 771 [REVIEW]

Xerosis / xeroderma

• (2017): Segaert S+, Am J Clin Dermatol 18(6), 771 [REVIEW]

Alopecia / hair loss

• (2017): Segaert S+, Am J Clin Dermatol 18(6), 771 [REVIEW]

Alopecia areata

• (2017): Craddock LN+, Dermatol Online J 23(3), Epub
• (2013): Griffith JL+, J Drugs Dermatol 12(6), 713

Scalp psoriasis

• (2023): Baniel A+, J Psoriasis Psoriatic Arthritis 8(3), 90-95 (6 cases)

Pleuropericarditis

• (2020): Zhang Q+, Int Immunopharmacol Oct, Online ahead of print [REVIEW]

Demyelinating neuropathy / demyelination

• (2019): Niimi N+, Adv Exp Med Biol 1190, 357 [REVIEW]

Mania

• (2022): Miola A+, Psychiatry Clin Neurosci 76(1), 15-21 [REVIEW] (association)

Gastrointestinal perforation / perforated colon / gastric perforation

• (2015): McAuliffe ME+, Curr Med Res Opin 31(9), 1655

Neutropenia (neutrophils decreased)

Infusion-site reactions

• (2018): Andrade P+, Dig Dis Sci Jan, Epub ahead of print4%
• (2017): Pecoraro V+, Autoimmun Rev 16(6), 56417% [REVIEW]

Injection-site reaction

• (2018): Andrade P+, Dig Dis Sci Jan, Epub ahead of print4%
• (2017): Ma Z+, Medicine (Baltimore) 96(25), e7145 [REVIEW]

Ocular adverse effect

• (2020): Nicolela Susanna F+, J Ophthalmic Inflamm Infect 10(1), 11 [REVIEW]

Optic neuritis / papillitis

• (2016): Alexandre B+, J Crohns Colitis 10(5), 541-8 (10 cases) (association)

Uveitis / anterior uveitis / posterior uveitis / panuveitis

• (2015): Cordero-Coma M+, Expert Opin Drug Saf 14(1), 111 [REVIEW]
• (2015): Pagnini C+, Expert Opin Drug Saf 14(1), 31 [REVIEW]

Nephrolithiasis (kidney stones / renal calculi)

• (2015): McAuliffe ME+, Curr Med Res Opin 31(9), 1655

Pulmonary toxicity

• (2014): Roubille C+, Semin Arthritis Rheum 43(5), 613 [REVIEW]

Adverse effects / adverse reactions

• (2024): Zheng B+, Medicine (Baltimore) 103(29), e39012 [REVIEW] (pharmacovigilance / pharmacoepidemiology)
• (2021): De Felice KM+, J Allergy Clin Immunol 148(3), 661-667 [REVIEW]
• (2020): Atzeni F+, Expert Opin Drug Saf May, Epub ahead of print [REVIEW]
• (2017): Garcia-Lagunar MH+, Ann Pharmacother 51(5), 388
• (2017): Ma Z+, Medicine (Baltimore) 96(25), e7145 [REVIEW]
• (2017): Pecoraro V+, Autoimmun Rev 16(6), 564 [REVIEW]

Allergic reactions

• (2017): Jamilloux Y+, Semin Arthritis Rheum 47(2), 2888%
• (2015): Petrikova J+, Isr Med Assoc J 17(4), 256

Cancer

• (2015): McAuliffe ME+, Curr Med Res Opin 31(9), 1655 (gastrointestinal / including anal and rectal cancer)

Infection

• (2018): Andrade P+, Dig Dis Sci Jan, Epub ahead of print14%
• (2017): Jamilloux Y+, Semin Arthritis Rheum 47(2), 28836%
• (2017): Marquet A+, Sarcoidosis Vasc Diffuse Lung Dis 34(1), 74-80 (5 cases)
• (2017): Pecoraro V+, Autoimmun Rev 16(6), 56430% [REVIEW]
• (2017): Segaert S+, Am J Clin Dermatol 18(6), 771 [REVIEW] (cutaneous)
• (2015): McAuliffe ME+, Curr Med Res Opin 31(9), 1655
• (2015): Murdaca G+, Expert Opin Drug Saf 14(4), 571 [REVIEW]
• (2015): Pagnini C+, Expert Opin Drug Saf 14(1), 31 [REVIEW]

Malignancies

• (2015): Beattie A+, J Oral Maxillofac Surg 73(11), 2136
• (2015): Pagnini C+, Expert Opin Drug Saf 14(1), 31 [REVIEW]